| Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726) |
|---|
| 02/07/2007 | EP1242382B1 Tricyclic protein kinase inhibitors |
| 02/07/2007 | CN1910189A Dual molecules containing peroxy derivative, the synthesis and therapeutic applications thereof |
| 02/07/2007 | CN1298720C Sinomenine derivative with C cycle connected to penetabasic heterocycle and synthesizing method |
| 02/07/2007 | CN1298718C Derivative of sinomenine with pyrazinc cyclc being connected to C cycle, synthetic method and application |
| 02/07/2007 | CN1298705C Novel piperidine-4-sulfamide compound, its preparing method and medicinal composition containing them |
| 02/06/2007 | US7173134 retinoid X receptors ("RXRs"); useful for the treatment of diabetes (NIDDIM) and obesity; for example, 3-{4-[(5,5,8,8-Tetramethyl-5,6,7,8-tetrahydro-2-naphthalenyl)methyl]-2-furyl}-2-propenoic acid |
| 02/06/2007 | US7173056 Condensed indoline derivatives and their use as 5HT, in particular 5HT2C, receptor ligands |
| 02/06/2007 | US7173042 Quinoline inhibitors of cGMP phosphodiesterase |
| 02/06/2007 | US7173029 Fused heteroaryl derivatives |
| 02/06/2007 | CA2641659A1 4-acylaminopyridine derivative mediated neurogenesis |
| 02/06/2007 | CA2090967C Water soluble camptothecin analogues, processes and methods |
| 02/01/2007 | WO2007013691A1 Spiro-cyclic compound |
| 02/01/2007 | WO2007013661A1 Percutaneously absorbable ophthalmic preparation |
| 02/01/2007 | US20070027321 Bipyridyl amines and ethers as modulators of metabotropic glutamate receptor-5 |
| 02/01/2007 | US20070027320 New Process for the Production of Tiotropium Salts |
| 02/01/2007 | US20070027317 Hetero diels-alder adducts of pentacene as soluble precursors of pentacene |
| 02/01/2007 | US20070027156 Crf antagonists and heterobicyclic compounds |
| 02/01/2007 | US20070027145 Quinazoline derivatives as inhibitors of vegf receptor tyrosine kinases |
| 02/01/2007 | US20070027143 Novel substituted 2,3-benzodiazepine derivatives |
| 02/01/2007 | US20070027140 {2-[(1-cyclopropylmethyl-6-fluoro-1H-indole-3-carbonyl)-amino]-thiazol-5-ylsulfanyl}-acetic acid, used for treating non-insulin dependent diabetes, dyslipidemia, hyperlipidemia, hypertension, obesity and as dietetics |
| 02/01/2007 | US20070027138 Derivatives and analogs of galanthamine |
| 02/01/2007 | US20070027134 Crystal form of asenapine maleate |
| 02/01/2007 | US20070027133 Bicyclic pyrazolyl and imidazolyl compounds and uses thereof |
| 02/01/2007 | CA2617042A1 Spiro-cyclic compound |
| 01/31/2007 | EP1747206A1 Amino-tetrazoles analogues and methods of use |
| 01/31/2007 | EP1747196A2 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication |
| 01/31/2007 | CN1906200A Novel compounds |
| 01/31/2007 | CN1906173A Protein modifier production inhibitor |
| 01/31/2007 | CN1905873A Bicyclic inhibitors of MEK and methods of use thereof |
| 01/31/2007 | CN1903856A Preparation method of Tetrandrine and Fangchino-kine |
| 01/31/2007 | CN1297556C New benzo[b]chromeno-naphthyridin-7-one and pyrano[2',3':7,8] quino[2,3-b]quinoxalin-7-one compounds, process for their preparation and pharmaceutical compositions containing them |
| 01/31/2007 | CN1297550C Benzofuran derivatives, process for the preparation of the same and uses thereof |
| 01/30/2007 | US7169926 Dipeptidyl peptidase inhibitors |
| 01/30/2007 | US7169922 Derivatives of 1,2-dihydro-7-hydroxyquinolines containing fused rings |
| 01/30/2007 | US7169774 Purification of natural, synthetic or semi-synthetic crude harringtonines by reverse phase chromatography and crystallization; solvent is water or lower alkanol, or an aqueous mixture of organic solvents; enantiomerically pure; industrial scale; leukemia chemotherapy |
| 01/30/2007 | CA2238316C N-([1,2,4]triazoloazinyl)benzenesulfonamide and pyridinesulfonamide compounds and their use as herbicides |
| 01/25/2007 | WO2007011811A1 Spirochromanone derivatives as acetyl coenzyme a carboxylase (acc) inhibitors |
| 01/25/2007 | WO2007011809A1 Spirochromanone derivatives as acetyl coenzyme a carboxylase (acc) inhibitors |
| 01/25/2007 | WO2007011290A1 Bronchorelaxing agents based on indol- and isoquinoline derivatives |
| 01/25/2007 | WO2007010383A1 Novel heterocyclidene acetamide derivative |
| 01/25/2007 | WO2007009953A1 Process for preparing 2-methoxycarbonylmethyl-6,6-dimethyl-2- tetrahydropyran carboxylic acid |
| 01/25/2007 | WO2006110654A8 Spiroheterocyclic compounds and their uses as therapeutic agents |
| 01/25/2007 | WO2006098855A3 Processes for preparing morphinans and intermediates thereof |
| 01/25/2007 | WO2006084941A3 Process for the preparation of irinotecan hydrochloride |
| 01/25/2007 | US20070021480 Biologically active compounds obtainable from Sorangium cellulosum |
| 01/25/2007 | US20070021479 Phorboxazole compounds and methods of their preparation |
| 01/25/2007 | US20070021464 Methods and compositions for inhibition of angiogenesis with EM-12 Derivatives |
| 01/25/2007 | US20070021442 HIV reverse transcriptase inhibitors |
| 01/25/2007 | US20070021423 Dual molecules containing peroxy derivative, the synthesis and therapeutic applications thereof |
| 01/25/2007 | CA2614963A1 Spirochromanone derivatives as acetyl coenzyme a carboxylase (acc) inhibitors |
| 01/25/2007 | CA2607811A1 Syntheses and preparations of narwedine and related novel compounds |
| 01/24/2007 | EP1745052A1 Hiv integrase inhibitors: cyclic pyrimidinone compounds |
| 01/24/2007 | EP1745051A1 Thienopyridazines as ikk inhibitors |
| 01/24/2007 | EP1745050A1 Thienopyridines as ikk inhibitors |
| 01/24/2007 | EP1745048A2 Simple stereocontrolled synthesis of salinosporamide a |
| 01/24/2007 | EP1377555B1 A dioxino[2,3-g]quinoline-9-carboxylic acid derivative as nk3 receptor antagonist |
| 01/24/2007 | CN1902196A Thiazole derivative |
| 01/24/2007 | CN1902190A 2-(hetero-)aryl substituted tetrahydroquinoline derivatives |
| 01/24/2007 | CN1902171A Benzylether amine compounds useful as CCR-5 antagonists |
| 01/24/2007 | CN1900080A Inhibitors of cruzipain and other cysteine proteases |
| 01/24/2007 | CN1900067A Tricyclic compounds, their production and use |
| 01/23/2007 | US7166723 5-hydroxy- or 1-glyceryl-substituted quinolines, isoquinolines or cinnolines as chemical intermediates |
| 01/23/2007 | US7166720 Process for the preparation of α-aminosubstituted carboxylic acid amides |
| 01/23/2007 | US7166632 such as (S)-1-(2,3,7,8-tetrahydrofuro[2,3-g]indol-1-yl)-2-propylamine; serotonin receptor antagonists (5HT/5HT2C); for treatment of obesity |
| 01/23/2007 | US7166617 Cyclic amide derivatives |
| 01/23/2007 | US7166614 CCR-2 modulators; INFLAMMATORY, IMMUNOREGULATORY, ALLERGIC, AND AUTOIMMUNE DISORDERS AND DISEASES |
| 01/23/2007 | US7166613 Condensed indoline derivatives and their use as 5HT, in particular 5HT2c, receptor ligands |
| 01/23/2007 | US7166600 Resistant to metabolism, improved half-life and/or clearance properties compared to corresponding carbamates; e.g N-(2-chlorobenzoyl)-p-(morpholinothiocarbonyloxy)tyrosine; used to treat inflammatory diseases e.g rheumatoid arthritis, asthma, psoriasis, multiple sclerosis, inflammatory bowel disease |
| 01/23/2007 | US7166598 Piperazine derivatives |
| 01/23/2007 | US7166588 Derivatives and analogs of galanthamine |
| 01/23/2007 | US7166586 Sulfonamide lactam inhibitors of FXa and method |
| 01/23/2007 | US7166583 1,3-diaza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof |
| 01/23/2007 | CA2338311C Prodrugs of the pyridyl methyl sulfinyl benzimidazoles |
| 01/18/2007 | WO2007006715A1 Cysteine protease inhibitors |
| 01/18/2007 | WO2007006688A1 Indol-3-carbonyl-spiro-piperidine derivatives as v1a receptor antagonists |
| 01/18/2007 | WO2007006211A1 Dipeptidyl peptidase iv (ddp iv) inhibitors, preparation methods and uses thereof |
| 01/18/2007 | WO2006010967A8 Kynurenic acid amide derivatives as nr2b receptor antagonists |
| 01/18/2007 | US20070015819 Novel compounds |
| 01/18/2007 | US20070015785 Crystalline Micronisate, Process for the Manufacture Thereof and Use Thereof for the Preparation of a Medicament |
| 01/18/2007 | US20070015782 Benzimidazole compound |
| 01/18/2007 | US20070015751 Nitro and amino substituted heterocycles as topoisomerase I targeting agents |
| 01/18/2007 | US20070015746 Azepine derivaties as pharmaceutical agents |
| 01/18/2007 | US20070015731 5,6-Di-substituted oxadiazolopyrazines and thiadiazolopyrazines as CXC-chemokine receptor ligands |
| 01/18/2007 | US20070015664 2,4,6-Phenyl substituted cyclic ketoenols |
| 01/18/2007 | CA2615726A1 Indol-3-yl-carbonyl-spiro-piperidine derivatives as v1a receptor antagonists |
| 01/18/2007 | CA2612442A1 Heterotetracyclic compounds as tpo mimetics |
| 01/17/2007 | EP1742951A1 6,7-dihydroxy-8-phenyl-3,6,7,8-tetrahydro-chromeno[7, 8-d]imidazole derivatives and their use as gastric acid secretion inhibitors |
| 01/17/2007 | EP1742944A1 Indoles, 1h-indazoles, 1,2-benzisoxazoles, 1,2-benzoisothiazoles, and preparation and uses thereof |
| 01/17/2007 | EP1742914A1 Cyclobutenedione groups-containing compounds as inhibitors of hepatitis c virus ns3 serine protease |
| 01/17/2007 | EP1742907A2 Certain chemical entities, compositions, and methods |
| 01/17/2007 | EP1268444B1 2,4-di(hetero-)arylamino(-oxy)-5-substituted pyrmidines as antineoplastic agents |
| 01/17/2007 | CN1896078A Bicyclic pyrrolyl amides as glucogen phosphorylase inhibitors |
| 01/17/2007 | CN1896076A Tricyclic-type compound, and medicine having it as effective component |
| 01/17/2007 | CN1896070A 2- and 2,5-substituted phenylketo-enols |
| 01/17/2007 | CN1896064A Metabolites of ecteinascidin 743 |
| 01/16/2007 | US7164021 Intensify therapy of analgesics; immunology diseases; antiinflammatory agents; drug abuse; diarrhea; cardiovascular disorders; antisecretory agents; respiratory system disorders |
| 01/16/2007 | US7163947 1-Amino 1H-imidazoquinolines |
| 01/16/2007 | US7163946 Urogenital disorders; bleeding; hormone replacement therapy; anticancer agents; contraceptives |
| 01/16/2007 | CA2111372C Diaryl 5,6-fusedheterocyclic acids as leukotriene antagonists |
| 01/11/2007 | WO2006020959A3 Substituted benzofused heterocycles |